Aller au contenu principal
Accès ouvert déclaré 2025 article

Reassessing regional nodal radiotherapy strategies for breast cancer in the context of modern systemic treatments

3Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : tw. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: The efficacy of radiotherapy to the internal mammary node (IMN-RT) and axillary lymph node regions (ALRT) in enhancing disease-free survival (DFS) among patients with breast cancer (BC) in the context of contemporary systemic chemotherapy has not been clearly established. METHODS: This retrospective study included 512 patients with BC who underwent primary breast surgery and regional nodal irradiation between 2008 and 2014. The patient cohort was divided into 160 early-stage (T1-T2, N0-N1) and 352 locally advanced-stage (T3-T4, N2-N3) cases. We employed Kaplan-Meier survival analysis to calculate locoregional recurrence-free survival (LRFS), DFS, and overall survival (OS). A propensity score-matched (PSM) analysis was performed for patients who received IMN-RT. RESULTS: A high proportion of patients (95.9%) received adjuvant chemotherapy and 89.8% received taxane-based regimens. All HER2-positive patients were treated with anti-HER2 therapy, and hormone therapy was administered to 97.5% of the patients with ER-positive tumors. While all patients underwent supraclavicular fossa RT, only 20 patients (3.9%) received additional IMN-RT. ER-negative/HER2-negative patients demonstrated a significantly lower 10-year DFS (p = 0.036) and OS (p = 0.006). PSM analysis showed that there were no differences in LRFS (p = 0.308) and DFS (p = 0.388) between patients receiving IMN-RT and those who did not. For pathological N3 patients, the 10-year LRFS (67% vs. 81.7%, p = 0.153) and DFS (62.3% vs. 64.9%, p = 0.789) rates were similar between those who underwent ALRT and those without ALRT. CONCLUSION: In the modern era of systemic therapy, RT to the IMN or axilla does not substantially improve the clinical outcomes in patients with LN-positive early- or locally advanced-stage BC.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Reassessing regional nodal radiotherapy strategies for breast cancer in the context of modern systemic treatments
Date Crossref
01/05/2026
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Breast Cancer Treatment StudiesBreast Lesions and CarcinomasBreast Implant and Reconstruction

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.